Compound Detail
CHEMBL3301612
ENCORAFENIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1
Basic Information
| ChEMBL ID | CHEMBL3301612 |
| Name | ENCORAFENIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
| Therapeutic | ✓ Yes |
22
Targets
31
Activities
3
Assay Types
5
PK Parameters
20
Publications
7
Known Names
17
Indications
1
Mechanisms
Molecular Properties
540.0
MW (Da)
3.91
ALogP
9
HBA
3
HBD
140.1
PSA (Ų)
0.37
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2018 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase B-raf inhibitor | INHIBITOR | Serine/threonine-protein kinase B-raf | ✓ | ✓ |
Indications
Colorectal Neoplasms Colorectal Neoplasms Colorectal Neoplasms Melanoma Melanoma Melanoma Neoplasms Neoplasms Biliary Tract Neoplasms Carcinoma, Non-Small-Cell Lung Leukemia, Hairy Cell Multiple Myeloma Pancreatic Neoplasms Pulmonary Disease, Chronic Obstructive Thyroid Neoplasms Carcinoma, Pancreatic Ductal Skin Neoplasms
ATC Classification
L01EC03
encorafenib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
Kd 20 meas. best 7.58
IC50 10 meas. best 9.52
EC50 1 meas. best 8.4
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 16200.6 | ng.hr.mL-1 | Mus musculus |
| CL | 4.3 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 27000.0 | nM | Mus musculus |
| F | 43.0 | % | Mus musculus |
| T1/2 | 24.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| 26298497 | 10.1016/j.bmcl.2015.07.093 | Homo sapiens | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-dependent L-type calcium channel subunit alpha-1C | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 29191878 | 10.1126/science.aan4368 | Actin-related protein 2 | 1 |
| 39077892 | 10.1021/acs.jmedchem.4c00998 | Unchecked | 1 |
| 29191878 | 10.1126/science.aan4368 | Activin receptor type-1 | 1 |
| 29191878 | 10.1126/science.aan4368 | Actin-related protein 3 | 1 |
| 29191878 | 10.1126/science.aan4368 | Acyl-CoA dehydrogenase family member 10 | 1 |
| 29191878 | 10.1126/science.aan4368 | Tyrosine-protein kinase ABL2 | 1 |
Data from ChEMBL 36 via Core Engine